PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma Company focused on developing and commercializing innovative gene ...

Most of us use some sort of production timeline in manufacturing our wood products. If the finished product is to be done in 8 weeks, the raw material must arrive in 2 weeks, the basic cutting done in ...

Cell and gene therapies (CGTs) have begun to transform the landscape of therapeutic offerings for patients with genetic diseases and other medical conditions. For many emerging biopharmaceutical ...

With an upsized production goal of 2 billion COVID-19 vaccine doses this year, Pfizer and its German partner BioNTech aren’t resting on their laurels now that their shot, Comirnaty, has emergency nods ...

AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.

Slate broke onto America's automotive scene earlier this year, emerging from stealth mode operations to become one of the most talked-about brands in 2025. It plans to manufacture and sell a ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Manufacturers are quickly understanding the strategic ...

SAN FRANCISCO/SINGAPORE, March 3 (Reuters) - Chip designers Nvidia (NVDA.O), opens new tab and Broadcom (AVGO.O), opens new tab are running manufacturing tests with Intel (INTC.O), opens new tab, two ...

SAN FRANCISCO, Aug 5 (Reuters) - The production process that Intel (INTC.O), opens new tab hoped would pave the way to winning manufacturing deals and restore its edge in churning out high-end, ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...

Chip designers Nvidia and Broadcom are running manufacturing tests with Intel, two sources familiar with the matter told Reuters, demonstrating early confidence in the struggling company's advanced ...